JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online May 15, 2007, 10.2967/jnumed.106.038075
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.106.038075v1
48/6/926    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, S.
Right arrow Articles by Parsey, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, S.
Right arrow Articles by Parsey, R. V.
Journal of Nuclear Medicine Vol. 48 No. 6 926-931
© 2007 by Society of Nuclear Medicine
doi: 10.2967/jnumed.106.038075

Clinical Investigation

Optimal Metabolite Curve Fitting for Kinetic Modeling of 11C-WAY-100635

Songmei Wu1, R. Todd Ogden2–4,, J. John Mann3,4,5 and Ramin V. Parsey3,4

1 New York City Department of Health and Mental Hygiene, New York, New York; 2 Department of Biostatistics, Columbia University School of Public Health, New York, New York; 3 Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York; 4 Department of Neuroscience, New York State Psychiatric Institute, New York, New York; and 5 Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York

Correspondence: For correspondence or reprints contact: R. Todd Ogden, PhD, Columbia University, Department of Biostatistics, 6th Floor, 722 W. 168th St., New York, NY 10032. E-mail: to166{at}columbia.edu

Many quantitative imaging protocols that make use of a metabolite-corrected arterial input function require the use of a mathematic model to describe the rate of metabolism of the radioligand. Commonly, parametric models are fit to metabolism data and then the fitted model is used to correct the plasma input function. 11C-WAY 100635 is a rapidly metabolized radioligand used extensively in mapping the 5-hydroxytryptamine receptor 1A system. Methods: To evaluate the adequacy of fit of 4 metabolite models, we examined data from 92 subjects who received an injection of 11C-WAY 100635, were imaged with PET, and underwent measurement of total plasma concentration and metabolites. The performance of these models was assessed according to residual plots, as well as fit and information criteria. Results: The study showed that the choice of model has a substantial effect on the resulting estimates of outcome measures. Conclusion: Among the models considered, the Hill model provides the best fit across all criteria.

Key Words: nonlinear modeling • residual analysis • kinetic modeling

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  



This article has been cited by other articles:


Home page
 JNMHome page
M. S. Milak, A. J. Severance, R. T. Ogden, J. Prabhakaran, J.S. D. Kumar, V. J. Majo, J. J. Mann, and R. V. Parsey
Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET
J. Nucl. Med., April 1, 2008; 49(4): 587 - 596.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.